Rupert Waterhouse and Carl Friderichsen: adrenal apoplexy

J Varon1, K Chen, G L Sternbach

  • 1Pulmonary and Critical Care Section, Baylor College of Medicine, The Methodist Hospital, Houston, Texas 77030, USA.

Insights

Waterhouse-Friderichsen (WFS) syndrome, or purpura fulminans, causes acute adrenal gland necrosis, often from meningococcal infection. Early recognition of vague symptoms and petechiae is crucial for prompt treatment in this pediatric-leaning, high-mortality condition.

Area of Science:

  • Pediatric Infectious Diseases
  • Endocrinology
  • Critical Care Medicine

Background:

  • Waterhouse-Friderichsen (WFS) syndrome, also known as purpura fulminans, is a life-threatening condition characterized by acute hemorrhagic necrosis of the adrenal glands.
  • It is most commonly caused by Neisseria meningitidis infection and predominantly affects the pediatric population, carrying high rates of morbidity and mortality.
  • Initial symptoms are often nonspecific and vague, including fever, malaise, and respiratory or musculoskeletal complaints, making early diagnosis challenging.

Discussion:

  • The clinical presentation of WFS can range from subtle, non-toxic appearing illness to rapidly progressing purpura fulminans.
  • The presence of fever and petechiae should raise suspicion for WFS, even in the absence of a toxic appearance.
  • Delayed diagnosis significantly worsens patient outcomes due to the rapid and severe nature of the disease.

Key Insights:

  • WFS diagnosis requires a high index of suspicion, especially in children presenting with fever and petechiae.
  • Nonspecific initial symptoms can mimic benign viral illnesses, complicating early recognition.
  • Prompt initiation of therapy upon suspicion is critical to improve survival rates.

Outlook:

  • Further research into earlier diagnostic markers and targeted therapies for WFS is warranted.
  • Improved awareness among healthcare providers regarding the diverse presentations of WFS can facilitate timely intervention.
  • Enhanced understanding of the pathophysiology may lead to novel treatment strategies for purpura fulminans.